We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

48 hedge funds and large institutions have $22.3M invested in Anavex Life Sciences in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.27% less ownership

Funds ownership: 20.36% → 18.08% (-2.3%)

6% less capital invested

Capital invested by funds: $23.8M → $22.3M (-$1.5M)

16% less funds holding

Funds holding: 57 → 48 (-9)

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

80% less call options, than puts

Call options by funds: $251K | Put options by funds: $1.28M

Holders
48
Holders Change
-9
Holders Change %
-15.79%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
10
Reduced
16
Closed
14
Calls
$251K
Puts
$1.28M
Net Calls
-$1.03M
Net Calls Change
-$301K

Top Buyers

1
PWAM
Park West Asset Management
California
+$1.41M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$77.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$71.1K
4
JT
Jump Trading
Illinois
+$44.3K
5
RJFSA
Raymond James Financial Services Advisors
Florida
+$43K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$571K
2
PP
Paloma Partners
Connecticut
-$502K
3
ECM
Element Capital Management
New York
-$378K
4
LP
LMR Partners
United Kingdom
-$319K
5
BCM
BlueCrest Capital Management
Jersey
-$284K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$40K +$5.64K +2,000 +16%
GWM
27
Geneos Wealth Management
Colorado
$38K +$39.5K +14,000 New
TRCT
28
Tower Research Capital (TRC)
New York
$36K +$1.33K +473 +4%
Morgan Stanley
29
Morgan Stanley
New York
$30K -$238K -84,328 -88%
UBS Group
30
UBS Group
Switzerland
$30K +$1.61K +571 +6%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$29K +$29.5K +10,469 New
EWM
32
Edge Wealth Management
New York
$27K – – –
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$16K – – –
Simplex Trading
34
Simplex Trading
Illinois
$12K -$5.9K -2,093 -32%
LTFS
35
Ladenburg Thalmann Financial Services
Florida
$11K -$2.54K -900 -18%
AIM
36
Advantage Investment Management
Iowa
$8K – – –
MAM
37
Meeder Asset Management
Ohio
$6K +$4.25K +1,506 +177%
ASN
38
Advisory Services Network
Georgia
$4K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$3.58K – – –
Citigroup
40
Citigroup
New York
$3K -$121K -42,934 -98%
BFC
41
Bedel Financial Consulting
Indiana
$3K – – –
CG
42
Cutler Group
California
$2K – – –
Bank of America
43
Bank of America
North Carolina
$1K -$75.5K -26,765 -98%
AF
44
Advisornet Financial
Minnesota
$1K – – –
BWA
45
BDO Wealth Advisors
Florida
$1K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$1K – – –
ICM
47
IMS Capital Management
Oregon
$1K +$564 +200 New
PP
48
Paloma Partners
Connecticut
– -$502K -191,571 Closed
LP
49
LMR Partners
United Kingdom
– -$319K -121,705 Closed
GPCM
50
Granite Point Capital Management
Massachusetts
– -$262K -100,000 Closed
1
2
3

AVXL Hedge Fund Activity: Q3 2018 in Review

48 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2018, worth a combined $22.3M — down 6.3% from $23.8M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AVXL and 5 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Park West Asset Management, adding an estimated $1.41M. The largest seller was Goldman Sachs, cutting an estimated $571K.

  • 48 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2018, down from 57 in Q2 2018.
  • Funds reported $22.3M of Anavex Life Sciences stock for Q3 2018, down 6.3% quarter-over-quarter.
  • 5 funds opened new Anavex Life Sciences positions in Q3 2018 and 14 closed out, a net change of -9 holders.
  • The largest Anavex Life Sciences buyer in Q3 2018 was Park West Asset Management, an estimated $1.41M added.
  • The largest Anavex Life Sciences seller in Q3 2018 was Goldman Sachs, an estimated $571K sold.

Based on aggregated 13F filings for Q3 2018.